ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
Blue Chip Shares
3 no-brainer Australian stocks to buy with $7,000 right now
Growth Shares
The best ASX growth shares to hold for the next decade
Growth Shares
How to spot quality ASX growth shares to hold for decades
How to invest
How to think like Warren Buffett when picking ASX shares
How to invest
Just turned 40? Here's how much you could have by retirement if you invest $500 a month
Retirement
5 steps to retiring early with ASX dividend shares
52-Week Highs
16 ASX 200 shares roar to multi-year highs amid new market milestone
Blue Chip Shares
2 amazing ASX 200 blue chip shares to buy and hold forever
How to invest
How to turn $500 a month into $1 million on the ASX
Broker Notes
Buy ResMed and this ASX stock for 10%+ returns
How to invest
How to turn small savings into big wealth with ASX shares
How to invest
The easy way to grow a $100,000 ASX share portfolio from zero
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
